{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:22:48Z","timestamp":1770445368080,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13331-2","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:44:57Z","timestamp":1755153897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in the relationship between medication adherence and payer medical costs across three quality measures: results of a cohort study among medicare advantage beneficiaries"],"prefix":"10.1186","volume":"25","author":[{"given":"Sujith","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Nsiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taruja","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"2","key":"13331_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1176\/ps.49.2.196","volume":"49","author":"JA Cramer","year":"1998","unstructured":"Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49(2):196\u2013201. https:\/\/doi.org\/10.1176\/ps.49.2.196.","journal-title":"Psychiatr Serv"},{"key":"13331_CR2","unstructured":"Sabat\u00e9 E, editor. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization, 2003. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/42682. Accessed 5 June 2023."},{"issue":"5","key":"13331_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487\u201397. https:\/\/doi.org\/10.1056\/NEJMra050100.","journal-title":"N Engl J Med"},{"key":"13331_CR4","unstructured":"New England Healthcare Institute (NEHI). Thinking Outside the Pillbox: A System-Wide Approach to Improving Patient Medication Adherence for Chronic Disease. Cambridge, MA, New England Healthcare Institute.: 2009. Available: http:\/\/psnet.ahrq.gov\/issue\/thinking-outside-pillbox-system-wide-approach-improving-patient-medication-adherence-chronic. Accessed 3 June 2023."},{"issue":"9","key":"13331_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"SH Naderi","year":"2012","unstructured":"Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882. https:\/\/doi.org\/10.1016\/j.amjmed.2011.12.013.","journal-title":"Am J Med"},{"issue":"11","key":"13331_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/0003-4819-157-11-201212040-00538","volume":"157","author":"M Viswanathan","year":"2012","unstructured":"Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785\u201395. https:\/\/doi.org\/10.7326\/0003-4819-157-11-201212040-00538.","journal-title":"Ann Intern Med"},{"issue":"9","key":"13331_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1060028018765159","volume":"52","author":"JH Watanabe","year":"2018","unstructured":"Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018;52(9):829\u201337. https:\/\/doi.org\/10.1177\/1060028018765159.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"13331_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MLR.0000000000001067","volume":"57","author":"JT Lloyd","year":"2019","unstructured":"Lloyd JT, Maresh S, Powers CA, Shrank WH, Alley DE. How much does medication nonadherence cost the Medicare fee-for-service program? Med Care. 2019;57(3):218\u201324. https:\/\/doi.org\/10.1097\/MLR.0000000000001067.","journal-title":"Med Care"},{"issue":"6","key":"13331_CR9","first-page":"459","volume":"16","author":"RE Aubert","year":"2010","unstructured":"Aubert RE, Yao J, Xia F, Garavaglia SB. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care. 2010;16(6):459\u201366.","journal-title":"Am J Manag Care"},{"issue":"1","key":"13331_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1377\/hlthaff.2009.1087","volume":"30","author":"MC Roebuck","year":"2011","unstructured":"Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91\u20139. https:\/\/doi.org\/10.1377\/hlthaff.2009.1087.","journal-title":"Health Aff"},{"issue":"9","key":"13331_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1176\/appi.ps.201100328","volume":"63","author":"RA Hansen","year":"2012","unstructured":"Hansen RA, Maciejewski M, Yu-Isenberg K, Farley JF. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs. Psychiatr Serv. 2012;63(9):920\u20138. https:\/\/doi.org\/10.1176\/appi.ps.201100328.","journal-title":"Psychiatr Serv"},{"issue":"10","key":"13331_CR12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.18553\/jmcp.2014.20.10.994","volume":"20","author":"MC Roebuck","year":"2014","unstructured":"Roebuck MC. Medical cost offsets from prescription drug utilization among medicare beneficiaries. J Manag Care Pharm. 2014;20(10):994\u20135. https:\/\/doi.org\/10.18553\/jmcp.2014.20.10.994.","journal-title":"J Manag Care Pharm"},{"issue":"6","key":"13331_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/MLR.0000000000000360","volume":"53","author":"BC Stuart","year":"2015","unstructured":"Stuart BC, Dai M, Xu J, Loh F-HE, Dougherty S. Does good medication adherence really save payers money? Med Care. 2015;53(6):517\u201323. https:\/\/doi.org\/10.1097\/MLR.0000000000000360.","journal-title":"Med Care"},{"key":"13331_CR14","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2147\/PPA.S107543","volume":"10","author":"KS Boye","year":"2016","unstructured":"Boye KS, Curtis SE, Lage MJ, Garcia-Perez L-E. Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a medicare supplemental database. Patient Prefer Adherence. 2016;10:1573\u201381. https:\/\/doi.org\/10.2147\/PPA.S107543.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"13331_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0000000000000870","volume":"56","author":"MC Roebuck","year":"2018","unstructured":"Roebuck MC, Kaestner RJ, Dougherty JS. Impact of medication adherence on health services utilization in medicaid. Med Care. 2018;56(3):266\u201373. https:\/\/doi.org\/10.1097\/MLR.0000000000000870.","journal-title":"Med Care"},{"issue":"10","key":"13331_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMp1500445","volume":"372","author":"SM Burwell","year":"2015","unstructured":"Burwell SM. Setting value-based payment goals\u2013HHS efforts to improve U.S. health care. N Engl J Med. 2015;372(10):897\u20139. https:\/\/doi.org\/10.1056\/NEJMp1500445.","journal-title":"N Engl J Med"},{"key":"13331_CR17","unstructured":"Centers for Medicare & Medicaid Services. Medicare 2022 Part C & D Star Ratings Technical Notes. Available: https:\/\/www.cms.gov\/files\/document\/2022-star-ratings-technical-notes-oct-4-2022.pdf. Accessed 6 June 2023."},{"key":"13331_CR18","unstructured":"Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services. 2021 National Impact Assessment of the Centers for Medicare & Medicaid Services (CMS) Quality Measures Report. Baltimore, MD:. 2021. Available: https:\/\/www.cms.gov\/files\/document\/2021-national-impact-assessment-report.pdf. Accessed 6 June 2023."},{"key":"13331_CR19","unstructured":"Pharmacy Quality A. 2022 PQA Measure Manual: Proportion of Days Covered: Renin Angiotensin System Antagonists (PDC-RASA). 2022. https:\/\/www\u00a0Accessed 8 Apr 2024."},{"key":"13331_CR20","unstructured":"Pharmacy Quality Alliance. 2022 PQA Measure Manual: Proportion of Days Covered: Statins (PDC-STA). 2022. https:\/\/www.pqaalliance.org\/measures-overview#pdc-sta. Accessed 8 Apr 2024."},{"key":"13331_CR21","unstructured":"Pharmacy Quality A. 2022 PQA Measure Manual: Proportion of Days Covered: Diabetes All Class (PDC-DR). 2022. https:\/\/www.pqaalliance.org\/measures-overview#pdc-dr. Accessed 8 Apr 2024."},{"key":"13331_CR22","doi-asserted-by":"publisher","first-page":"217047","DOI":"10.1155\/2015\/217047","volume":"2015","author":"WY Lam","year":"2015","unstructured":"Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. https:\/\/doi.org\/10.1155\/2015\/217047.","journal-title":"Biomed Res Int"},{"issue":"1","key":"13331_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1524-4733.2006.00139.x","volume":"10","author":"AM Peterson","year":"2007","unstructured":"Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10(1):3\u201312. https:\/\/doi.org\/10.1111\/j.1524-4733.2006.00139.x.","journal-title":"Value Health"},{"key":"13331_CR24","volume-title":"Proportion of days covered (PDC) as a preferred method of measuring medication adherence","author":"DP Nau","year":"2012","unstructured":"Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Alexandria, VA: Pharmacy Quality Alliance; 2012."},{"issue":"2","key":"13331_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/pds.3936","volume":"25","author":"MJ Korhonen","year":"2016","unstructured":"Korhonen MJ, Ruokoniemi P, Ilom\u00e4ki J, Meretoja A, Helin-Salmivaara A, Huupponen R. Adherence to Statin therapy and the incidence of ischemic stroke in patients with diabetes. Pharmacoepidemiol Drug Saf. 2016;25(2):161\u20139. https:\/\/doi.org\/10.1002\/pds.3936.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"13331_CR26","doi-asserted-by":"publisher","unstructured":"Babitsch B, Gohl D, Von Lengerke T. Re-revisiting andersen\u2019s behavioral model of health services use: a systematic review of studies from 1998\u20132011. GMS Psycho-Social-Medicine. 2012;9(Doc11). https:\/\/doi.org\/10.3205\/psm000089.","DOI":"10.3205\/psm000089"},{"key":"13331_CR27","unstructured":"Parikh M, Nsiah I, Campbell P, Ramachandran S, Karmarkar T, Castora-Brinkley M, Black H, Bentley JP. Medication Adherence and Subsequent Year Payer Medical Costs Among Medicare Advantage Beneficiaries: Differences across Quality Measures. ISPOR Annual Meeting. 2023. Available: https:\/\/www.ispor.org\/conferences-education\/conferences\/past-conferences\/ispor-2023\/program\/program\/paper\/intl2023-3682\/16030\/medication-adherence-and-subsequent-year-payer-medical-costs-among-medicare-advantage-beneficiaries-differences-across-quality-measures. Accessed 29 July 2025."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13331-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:45:01Z","timestamp":1755153901000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13331-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13331"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13331-2","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The conduct of the research was performed in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SR and JB report consulting fees from Pharmacy Quality Alliance, Inc. PC, HB, and TK are full-time employees of Merck & Co., Inc., Rahway, NJ, USA. HB owns stock in Merck & Co., Inc., Rahway, NJ, USA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1078"}}